To include your compound in the COVID-19 Resource Center, submit it here.

HuMax-CD4: Phase II data; Phase III

GEN said the combination of its HuMax-CD4 and methotrexate did not meet the primary endpoint

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE